Li, D., Loriot, Y., Burgoyne, A. M., Cleary, J. M., Santoro, A., Lin, D., . . . Paulson, S. (2024). Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: Results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Research in context. Elsevier.
Chicago Style (17th ed.) CitationLi, Daneng, et al. Cabozantinib Plus Atezolizumab in Previously Untreated Advanced Hepatocellular Carcinoma and Previously Treated Gastric Cancer and Gastroesophageal Junction Adenocarcinoma: Results from Two Expansion Cohorts of a Multicentre, Open-label, Phase 1b Trial (COSMIC-021)Research in Context. Elsevier, 2024.
MLA (9th ed.) CitationLi, Daneng, et al. Cabozantinib Plus Atezolizumab in Previously Untreated Advanced Hepatocellular Carcinoma and Previously Treated Gastric Cancer and Gastroesophageal Junction Adenocarcinoma: Results from Two Expansion Cohorts of a Multicentre, Open-label, Phase 1b Trial (COSMIC-021)Research in Context. Elsevier, 2024.